CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Sep. 27, 2013	Sep. 28, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net earnings	$ 438,248	$ 427,049	$ 398,933
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	42,637	47,876	42,018
Tax benefits from exercises of share-based payment awards	10,708	7,888	24,441
Excess tax benefits from share-based compensation	(9,583)	(8,929)	(22,570)
Depreciation	58,527	56,103	49,643
Amortization of intangible assets	4,332	4,879	2,948
Deferred taxes	(3,946)	(2,349)	35,230
Provision for doubtful accounts receivable	5,984	10,350	2,514
Income on equity investment in affiliate	(2,461)	(245)	(4,276)
Change in fair value of contingent consideration	(5,190)	0	0
Other, net	1,673	1,265	(398)
Changes in assets and liabilities, net of effect of acquisitions:
Accounts receivable	(43,301)	(87,434)	(41,577)
Inventories	(76,400)	(42,459)	(42,235)
Prepaid expenses and other assets	(15,694)	(47,029)	(13,288)
Accounts payable	7,784	19,275	35,524
Accrued expenses and other liabilities	(32,731)	37,748	(15,758)
Deferred revenues and advance payments from customers	74,598	68,787	21,630
Net cash provided by operating activities	455,185	492,775	472,779
Cash flows from investing activities:
Purchases of property, plant and equipment	(76,277)	(61,103)	(70,928)
Investment in corporate debt security	(10,044)	(30,503)	(19,205)
Investment in a privately held company	0	0	(13,597)
Acquisition of businesses, net of cash acquired	0	(28,241)	(9,124)
Net amounts received from (paid to) deferred compensation plan (“DCP”) trust account	(309)	(2,960)	48
Note repayments (receivable) from related party	0	8,800	(781)
Note receivable from other	(10,000)	0	0
Other	359	(8,288)	(4,345)
Net cash used in investing activities	(96,271)	(122,295)	(117,932)
Cash flows from financing activities:
Repurchases of common stock	(419,933)	(257,440)	(505,284)
Equity forward contracts	0	0	(105,562)
Proceeds from issuance of common stock to employees	129,582	60,332	137,697
Excess tax benefits from share-based compensation	9,583	8,929	22,570
Employees’ tax withheld and paid for restricted stock and restricted stock units	(9,560)	(10,122)	(14,815)
Net borrowings (repayments) under line of credit agreements	(155,000)	(26,400)	161,400
Borrowings under the term loan facility	500,000	0	0
Repayments on bank borrowings	0	(9,876)	(7,264)
Other	(3,026)	(99)	(77)
Net cash provided by (used in) financing activities	51,646	(234,676)	(311,335)
Effects of exchange rate changes on cash and cash equivalents	2,731	4,309	724
Net increase in cash and cash equivalents	413,291	140,113	44,236
Cash and cash equivalents at beginning of fiscal year	704,570	564,457	520,221
Cash and cash equivalents at end of fiscal year	$ 1,117,861	$ 704,570	$ 564,457